GlassScriptPhysician profile
Casey L Busmente
NPI 1487911244
$895.17
in general payments reported to CMS, 2019-2025
13 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $43.64 · 2023: $90.11 · 2024: $554 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.03 |
| Education | $158.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $195.35 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $160.93 | 2024-2025 | Dupixent |
| Lilly USA, LLC | $86.20 | 2023-2025 | Taltz, Ebglyss, Mounjaro |
| Ucb, INC. | $85.93 | 2024-2025 | Bimzelx |
| Amgen INC. | $65.60 | 2024-2025 | Otezla, Otezla |
| Incyte Corporation | $52.91 | 2024-2025 | Opzelura |
| Abbvie INC. | $50.96 | 2023-2024 | |
| Janssen Biotech, INC. | $47.67 | 2024-2025 | Tremfya, Simponi Aria, Simponi |
| Alkermes, INC. | $43.64 | 2022 | |
| Organon LLC | $40.08 | 2025 | Vtama |
| Sanofi Pasteur INC. | $26.66 | 2023 | |
| Shield Therapeutics INC | $21.24 | 2023 | Accrufer |
| Paratek Pharmaceuticals, INC. | $18.00 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Busmente listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.